So why are so few new antibiotics being successfully developed for medical use? Many pharmaceutical companies have left this area of research. On top of this, finding new and different types of ...

In an intensive Winter Session course at Brown, undergraduates learned lab techniques and performed experiments as they ...

However, there are no drugs being developed against class C ESBL-producing ... could present a major therapeutic challenge, and so new antibacterial drugs against class C ESBL-producing Gram ...

Small companies attempting to help solve a global crisis in drug-resistant infections with novel treatments are facing a wall ...

To overcome these challenges, the researchers developed ... yielded new molecules that displayed antibacterial activity against A. baumannii in vitro, it is unknown how well these chemicals will work ...

A new antibiotic against gram-negative bacteria hasn’t been developed since the 1970s ... there are five antibiotic development projects being supported within this platform.” ...